• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003

Giuseppe

Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]


Eurosurveillance, Volume 16, Issue 25, 23 June 2011
Research articles
Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003



S Lopo ()<SUP>1</SUP>, E Vinagre<SUP>1</SUP>, P Palminha<SUP>1</SUP>, M T Paix?o<SUP>1</SUP>, P Nogueira<SUP>2</SUP>, M G Freitas<SUP>3</SUP>
  1. Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal
  2. Department of Epidemiology, National Institute of Health, Lisbon, Portugal
  3. General Directorate of Health, Lisbon, Portugal
<HR>
Citation style for this article: Lopo S, Vinagre E, Palminha P, Paix?o MT, Nogueira P, Freitas MG. Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003. Euro Surveill. 2011;16(25):pii=19896. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19896
Date of submission: 04 January 2010
<HR>The prevalence of cytomegalovirus (CMV) infections ranges between 50% and 85% in adults in the United States, and its epidemiology varies in different regions of the world and between socioeconomic and age groups. In Portugal, no study has been carried out to date to determine the prevalence of CMV in the general population. Under the second National Serological Survey conducted in continental Portugal in 2001?2002, we estimated the prevalence of individuals with antibodies to CMV using indirect immunofluorescence to detect virus-specific IgG. The population sample included 2,143 individuals of both sexes and different ages from all 18 districts in Portugal. The national seroprevalence of CMV was determined as 77%. We analysed the proportion of CMV IgG by sex, age group and district of residence. This was the first nationally representative study of seroprevalence of CMV in Portugal. The results of the study indicate that CMV infection is highly prevalent in the population and occurs mainly in the first years of life.
- ------
 
Back
Top Bottom